Literature DB >> 16705184

E Proteins and Id2 converge on p57Kip2 to regulate cell cycle in neural cells.

Gerson Rothschild1, Xudong Zhao, Antonio Iavarone, Anna Lasorella.   

Abstract

A precise balance between proliferation and differentiation must be maintained during neural development to obtain the correct proportion of differentiated cell types in the adult nervous system. The basic helix-loop-helix (bHLH) transcription factors known as E proteins and their natural inhibitors, the Id proteins, control the timing of differentiation and terminal exit from the cell cycle. Here we show that progression into S phase of human neuroblastoma cells is prevented by E proteins and promoted by Id2. Cyclin-dependent kinase inhibitors (CKI) have been identified as key effectors of cell cycle arrest in differentiating cells. However, p57Kip2 is the only CKI that is absolutely required for normal development. Through the use of global gene expression analysis in neuroblastoma cells engineered to acutely express the E protein E47 and Id2, we find that p57Kip2 is a target of E47. Consistent with the role of Id proteins, Id2 prevents activation of p57Kip2 expression, and the retinoblastoma tumor suppressor protein, a known Id2 inhibitor, counters this activity. The strong E47-mediated inhibition of entry into S phase is entirely reversed in cells in which expression of p57Kip2 is silenced by RNA interference. During brain development, expression of p57Kip2 is opposite that of Id2. Our findings identify p57Kip2 as a functionally relevant target recruited by bHLH transcription factors to induce cell cycle arrest in developing neuroblasts and suggest that deregulated expression of Id proteins may be an epigenetic mechanism to silence expression of this CKI in neural tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16705184      PMCID: PMC1489106          DOI: 10.1128/MCB.01743-05

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  61 in total

1.  The two-domain hypothesis in Beckwith-Wiedemann syndrome.

Authors:  A P Feinberg
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

2.  Muscle-specific transcriptional activation by MyoD.

Authors:  H Weintraub; V J Dwarki; I Verma; R Davis; S Hollenberg; L Snider; A Lassar; S J Tapscott
Journal:  Genes Dev       Date:  1991-08       Impact factor: 11.361

3.  Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins.

Authors:  A Lasorella; A Iavarone; M A Israel
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

4.  Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor.

Authors:  F J Naya; C M Stellrecht; M J Tsai
Journal:  Genes Dev       Date:  1995-04-15       Impact factor: 11.361

5.  Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein.

Authors:  J E Lee; S M Hollenberg; L Snider; D L Turner; N Lipnick; H Weintraub
Journal:  Science       Date:  1995-05-12       Impact factor: 47.728

6.  Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors.

Authors:  W Y Chung; L Yuan; L Feng; T Hensle; B Tycko
Journal:  Hum Mol Genet       Date:  1996-08       Impact factor: 6.150

7.  The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein.

Authors:  A Iavarone; P Garg; A Lasorella; J Hsu; M A Israel
Journal:  Genes Dev       Date:  1994-06-01       Impact factor: 11.361

8.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.

Authors:  M H Lee; I Reynisdóttir; J Massagué
Journal:  Genes Dev       Date:  1995-03-15       Impact factor: 11.361

9.  A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.

Authors:  T D Littlewood; D C Hancock; P S Danielian; M G Parker; G I Evan
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

10.  Regulation of G1 progression by E2A and Id helix-loop-helix proteins.

Authors:  F A Peverali; T Ramqvist; R Saffrich; R Pepperkok; M V Barone; L Philipson
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

View more
  40 in total

1.  A network of broadly expressed HLH genes regulates tissue-specific cell fates.

Authors:  Abhishek Bhattacharya; Nicholas E Baker
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

2.  PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1.

Authors:  Wendy Roeb; Antonia Boyer; Webster K Cavenee; Karen C Arden
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-06       Impact factor: 11.205

Review 3.  Mechanisms controlling cell cycle exit upon terminal differentiation.

Authors:  Laura A Buttitta; Bruce A Edgar
Journal:  Curr Opin Cell Biol       Date:  2007-11-26       Impact factor: 8.382

4.  Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver.

Authors:  M J Gray; N A Dallas; G Van Buren; L Xia; A D Yang; R J Somcio; P Gaur; L S Mangala; P E Vivas-Mejia; F Fan; A M Sanguino; G E Gallick; G Lopez-Berestein; A K Sood; L M Ellis
Journal:  Oncogene       Date:  2008-09-22       Impact factor: 9.867

5.  MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state.

Authors:  Zhihong Yang; Kyle L MacQuarrie; Erwin Analau; Ashlee E Tyler; F Jeffery Dilworth; Yi Cao; Scott J Diede; Stephen J Tapscott
Journal:  Genes Dev       Date:  2009-03-15       Impact factor: 11.361

6.  Patterns of p57Kip2 expression in embryonic rat brain suggest roles in progenitor cell cycle exit and neuronal differentiation.

Authors:  Weizhen Ye; Georges Mairet-Coello; Elise Pasoreck; Emanuel Dicicco-Bloom
Journal:  Dev Neurobiol       Date:  2009-01       Impact factor: 3.964

7.  Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis.

Authors:  Francesco Niola; Xudong Zhao; Devendra Singh; Ryan Sullivan; Angelica Castano; Antonio Verrico; Pietro Zoppoli; Dinorah Friedmann-Morvinski; Erik Sulman; Lindy Barrett; Yuan Zhuang; Inder Verma; Robert Benezra; Ken Aldape; Antonio Iavarone; Anna Lasorella
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

8.  N-(4-Hydroxyphenyl) retinamide potentiated paclitaxel for cell cycle arrest and apoptosis in glioblastoma C6 and RG2 cells.

Authors:  Rajiv Janardhanan; Jonathan T Butler; Naren L Banik; Swapan K Ray
Journal:  Brain Res       Date:  2009-03-10       Impact factor: 3.252

Review 9.  In vivo genome-wide binding of Id2 to E2F4 target genes as part of a reversible program in mice liver.

Authors:  Ivan Ferrer-Vicens; Ángela L Riffo-Campos; Rosa Zaragozá; Concha García; Gerardo López-Rodas; Juan R Viña; Luis Torres; Elena R García-Trevijano
Journal:  Cell Mol Life Sci       Date:  2014-02-28       Impact factor: 9.261

10.  FHL2 interacts with and acts as a functional repressor of Id2 in human neuroblastoma cells.

Authors:  Weidong Han; Zhiqiang Wu; Yali Zhao; Yuanguang Meng; Yiling Si; Jie Yang; Xiaobing Fu; Li Yu
Journal:  Nucleic Acids Res       Date:  2009-05-05       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.